Intellia Therapeutics (NTLA) Other Working Capital Changes (2015 - 2026)

Intellia Therapeutics (NTLA) has 12 years of Other Working Capital Changes data on file, last reported at -$6.7 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 30.72% year-over-year to -$6.7 million in Q1 2026; TTM through Mar 2026 was -$29.7 million, a 36.11% decrease from a year earlier, with the FY2025 full-year figure at -$28.1 million, down 27.34% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$6.7 million, up from -$14.0 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for NTLA reached as high as $23.0 million in Q3 2025 and fell as low as -$19.2 million in Q2 2025.
• Historically, Other Working Capital Changes has averaged $2.4 million across 5 years, with a median of $1.2 million in 2022.
• Across the five-year window, Other Working Capital Changes tumbled 186.55% in 2022 and surged 308.83% in 2023, its largest moves.
• Year by year, Other Working Capital Changes stood at -$16.7 million in 2022, then jumped by 308.83% to $34.9 million in 2023, then plunged by 116.73% to -$5.8 million in 2024, then slumped by 139.18% to -$14.0 million in 2025, then soared by 52.36% to -$6.7 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$6.7 million in Q1 2026, -$14.0 million in Q4 2025, and -$4.9 million in Q3 2025.